Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 5/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

40%

2 trials in Phase 3/4

Results Transparency

75%

3 of 4 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 4

2(40.0%)

N/A

2(40.0%)

Phase 2

1(20.0%)

5Total

Phase 4(2)

N/A(2)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials

NCT07426003Not ApplicableNot Yet Recruiting

Healthy Volunteers Enteral Nutrition Study (HEN)

Role: lead

NCT00065065Phase 2Completed

A Trial of Rosiglitazone for Ulcerative Colitis

Role: lead

NCT00567593Phase 4Completed

Gene Regulation by Thiazolidinediones

Role: lead

NCT00652145Phase 4Completed

Dose Escalation and Remission (DEAR)

Role: lead

NCT00951756Not ApplicableCompleted

Controlled Feeding Experiment

Role: lead

All 5 trials loaded